Psychedelic Therapy
Research into psychedelics, shut down for decades, is now yielding exciting results - Michael Pollan
image by: aptmetaphor
HWN Recommends
Can Psychedelics Be Therapy? Allow Research to Find Out
In the last few years, calls for marijuana to be researched as a medical therapy have increased. It may be time for us to consider the same for psychedelic drugs.t
Two general classes of such drugs exist, and they include LSD, psilocybin, mescaline and ecstasy (MDMA).
All are illegal in the United States because they carry a high risk of abuse. They can also cause harm. The best-known adverse event is persistent flashbacks, though these are believed to be rare. More common are symptoms like increased heart rate and blood pressure, anxiety and panic.
Some people have pointed to anecdotal evidence of positive effects. Ayelet Waldman, a novelist and former federal…
Resources
Psychedelic medicines are expanding into the public consciousness
Magic mushrooms are just the start.
The psychedelic renaissance is at risk of missing the bigger picture
It’s been quite the journey for psychedelics, and it’s just getting started. First, they were sacred and ceremonial plant medicines for millennia. In the 1960s era, they traversed an American culture of mind expansion, which used them as wild tools for transcending ordinary states of consciousness. Then came the backlash in the 1970s when they were outlawed by a nervous Nixon administration. Now, psychedelics are emerging from the underground as a new generation of researchers amasses evidence that mind-altering drugs offer new and effective therapies to help stem the rising tides of mental illness.
Why psychedelic drugs could transform how we treat depression and mental illness
A conversation with author Michael Pollan on becoming a “reluctant psychonaut.”
Will the magic of psychedelics transform psychiatry?
Psychedelics have come a long way since their hallucinogenic hippy heyday. Research shows that they could alleviate PTSD, depression and addiction. So will we all soon be treated with magic mushrooms and MDMA?
Psychedelics Can Take You on a Healing Trip
Although it’s not news to a lot of us, even the purveyors of the ruinous failure known as the “War on Drugs” may be finally opening their eyes to the salubrious qualities of even the most prohibited of controlled substances.
5 Forgotten Drug Fads
Some drugs have dynamite PR. Methamphetamine pervades pop culture, iconized by a scowling Walter White and his pork pie hat. Crack cocaine, a mainstay of big-city life since the 1980s, remains in public consciousness with the help of hapless Toronto Mayor Rob Ford. Even bath salts and their designer-drug consorts got some well-earned name recognition two summers ago, as sensational headlines howled of faces eaten and an imminent zombie apocalypse. Other drugs are less fortunate. They wilt into obscurity, remembered only in the footnotes of old news articles. Let us take you through five of the world’s most bizarre and forgotten drug fads.
A Trip That Doesn’t End
Hallucinogens are enjoying something of a revival: the drugs are being tried recreationally by nearly one in five American adults (approaching that of the nineteen-sixties), while being tested empirically for their powers to heal alcoholism and other addictions, anxieties from impending death, P.T.S.D., major depression, and even cluster headaches.
Are Psychedelics The Wonder Drug We've Been Waiting For?
Two new studies have found no link between psychedelic use and a wide suite of mental health conditions, including schizophrenia, psychosis, depression, anxiety disorders and suicide attempts.
Can Psychedelic Drugs Treat Mental Illness? Scientists Need Your Help To Find Out.
A new crowdfunding campaign seeks to raise $2 million to advance promising research that the government has largely neglected.
Do Psychedelic Drug Laws Violate Human Rights?
The prohibition of MDMA and hallucinogenic mushrooms restricts "cognitive liberty," according to some activists.
Do Psychedelics Drive You Crazy Or Keep You Sane?
For antiprohibitionists who are wondering what comes next after marijuana legalization, this class of drugs seems like a good place to start.
LSD-Like Drugs Are Out of the Haze and Back in the Labs
At respected research centers in the United States and other countries, scientists have spent much of their professional lives in drug rehabilitation. It is not because they themselves struggle with addiction. What they are trying to rehabilitate are the drugs. Their focus is on mind-altering compounds that fell far from grace nearly half a century ago, LSD prominent among them.
Psychedelic drug use linked to fewer mental health problems
There is now an increasing push for more research into the potential benefits of psychedelics in medicine and in mental health. For example, psilocybin could help treat people with severe depression and LSD has been suggested to help people come to terms with a terminal illness. Obsessive Compulsive Disorder and treating alcohol dependence are two other areas where psychedelics could help. “Everything has some potential for negative effects, but psychedelic use is overall considered to pose a very low risk to the individual and to society,” Johansen said.
Psychedelic Drugs Don't Make People Crazy, Study Says
Researchers even found some associations between psychedelic drugs and fewer mental health issues.
Psychedelic Mushrooms And LSD Are Among The Safest Recreational Drugs, Survey Finds
Thousands of people reported using these drugs last year, and 1 percent or less sought medical attention.
Seeing Opportunity in Psychedelic Drugs
New research into LSD and psilocybin makes a powerful argument against prohibition.
Talking Acid Trips and Drug Legalization with the Psychedelic Society of Brooklyn
"The psychedelic experience has the potential to help a lot of people," said Daniel Miller, founder of the Psychedelic Society of Brooklyn.
The Promise of LSD Microdoses and Other Psychedelic
Psychiatrist John Halpern discusses the psychotherapeutic potential of peyote, ayahuasca, psilocybin, MDMA and other psychedelics.
The Trip Treatment
Research into psychedelics, shut down for decades, is now yielding exciting results.
The War on Drugs Halted Research Into the Potential Benefits of Psychedelics
Now it’s finally starting up again.
Turn On, Tune In, Get Better: Psychedelic Drugs Hold Medical Promise
Psychedelic drugs are poised to be the next major breakthrough in mental health care.
Psychedelics by David Nutt review – hope or hype?
An expert makes the case for psychedelic therapy, but we should beware the ‘Pollan effect’
The big idea: should doctors be able to prescribe psychedelics?
A move to allow Australian psychiatrists to treat depression with psilocybin may herald a new era.
The extraordinary therapeutic potential of psychedelic drugs, explained
I spent months talking to psychedelic guides and researchers. Here’s what I learned.
The New Science of Psychedelics
Recent studies are finding that drugs such as LSD and psilocybin can help to alleviate depression, anxiety and addiction—and may have profound things to teach us about how the mind works.
Can a Trip-Free Psychedelic Still Help People With Depression?
Psilocybin has shown promise for conditions like depression. Now, researchers are asking if the psychedelic experience is absolutely necessary to treat mental health.
Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy?
Scientists treating depression and a range of other mental illnesses have been running controlled trials using MDMA and psychedelic drugs such as LSD and the results have been encouraging.
Inside the Push to Legalize Magic Mushrooms for Depression and PTSD
Activists, entrepreneurs, and doctors in the US and Canada are working to decriminalize psilocybin psychotherapy and calling for a psychedelic revolution.
Is There A Case For Skepticism Of Psychedelic Therapy?
There’s been an explosion of interest in the use of psychedelics in psychiatry. Like everyone else, I hope this works out. But recent discussion has been so overwhelmingly positive that it’s worth reviewing whether there’s a case for skepticism. I think it would look something like this...
Johns Hopkins Opens New Center for Psychedelic Research
The research center, with $17 million from donors, aims to give “psychedelic medicine” a long-sought foothold in the scientific establishment.
Microdosing, Depression, and the Trippy Future of Mental Health Treatments
Psychedelics are a fringe frontier of mental health treatments. But are they safe?
One way to heal a brain injury? Let LSD open your mind—literally
Psychedelic drugs such as DMT and Ecstasy may offer a unique treatment pathway for various brain injuries and diseases because of their potency, helping patients learn lost and new skills.
Psychedelic medicine is coming—but who’s going to guide your trip?
The U.S. may approve therapies using MDMA and psilocybin—aka ecstasy and magic mushrooms. The medical community is preparing for the deluge of demand.
Psychedelic Retreats And The Future Of Mental Health: A Review
Some of Silicon Valley’s most prominent investors are betting that the eventual legalization of psychedelics could create the next big frontier in the mental health industry. For instance, Peter Thiel is behind one company, Compass, that has reportedly already made tens of thousands of doses of the active ingredient in magic mushrooms, Psilocybin, for the treatment of depression.
Psychedelic-Assisted Therapy Is Transforming the Way We Think About Mental Health Care
How mushrooms, LSD, MDMA, and ketamine could help treat mental illnesses.
Psychedelics might revolutionize therapy. What happens if you remove the trip?
“Tripless” drugs might open more opportunities for psychiatry. Just don’t call them psychedelics.
Psychedelics to treat mental illness? Australian researchers are giving it a go
We’re now beginning to understand the neurological mechanisms responsible for the mystical states and creative thinking psychedelics can produce, and how they can aid the treatment of anxiety and depression. Psychedelics reduce the activity of a neural circuit in the brain called the default mode network (DMN).
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
Tim Ferriss, the Man Who Put His Money Behind Psychedelic Medicine
The author of “The 4-Hour Workweek” is behind a surge in funding for clinical research into psychedelic drugs.
Why Psychedelic Drugs May Become a Key Treatment for PTSD and Depression
Ecstasy and the active ingredient in magic mushrooms have shown promise in clinical trials, but more testing is needed.
Why scientists want to create psychedelics that give better trips
Drugs modeled on natural compounds could help people with anxiety, depression, and addiction. But can side effects, like long-and-winding trips, be eliminated while keeping the therapeutic benefits?
‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health
Psychedelics … through whatever mechanisms, seem to represent a significant improvement over the standard therapies.
Can Psychedelics Be Therapy? Allow Research to Find Out
In the last few years, calls for marijuana to be researched as a medical therapy have increased. It may be time for us to consider the same for psychedelic drugs. Two general classes of such drugs exist, and they include LSD, psilocybin, mescaline and ecstasy (MDMA). All are illegal in the United States because they carry a high risk of abuse. They can also cause harm.
Compass
Founded in 2016, our first major initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression. We are taking a new approach to mental health and are committed to developing care pathways and therapies that will help patients and their families, and ease the burden on healthcare systems. Backed by a team of leading experts in medicine, mental health, business, and academia, we put the patient at the centre of everything we do.
Beckley Foundation
Since its creation by Amanda Feilding in 1998, the Beckley Foundation has been at the forefront of global drug policy reform and scientific research into psychoactive substances. We collaborate with leading scientific and political institutions worldwide to design and develop ground-breaking research and global policy initiatives.
Multidisciplinary Association for Psychedelic Studies
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
The Psychedelic Society
The Psychedelic Society advocates the careful use of psychedelics as a tool for awakening to the unity and interconnectedness of all things. You could say we advocate the use of psychedelics as endosyndelics (from the Greek endosyndesi: interconnection, delos: make visible, reveal). The profound experiences of unity and interconnectedness reliably brought about by strong psychedelic trips can help people to live lives of greater love, compassion and joy
Psychedelic Times
Our mission at Psychedelic Times is to share the latest news, research, and happenings around the study of psychedelics as tools of healing, recovery, and therapy. We are passionate about the incredible potential that psychoactive substances such as marijuana, ayahuasca, MDMA, LSD, iboga, psilocybin, and DMT present to humanity, and are excited to share that passion with you.
Introducing Stitches!
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.